Bahija Jallal

In her role at MedImmune, she is responsible for biologics research and development activities and advancing the biologics portfolio of medicines. She is also EVP of AstraZeneca, parent company of MedImmune. Previously, she was VP for drug assessment and development at Chiron Corp, and senior director of research at Sugen Inc., a subsidiary of Pfizer. She currently serves on the board of trustees of the Johns Hopkins University